Clinical Trials Browser

Completed × OTHER × HMPL-013 × Clear all

NCT06202599 2024-01-17

Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance

Bone Neoplasms, Neoplasms, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT06031376 2023-09-11

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Gastrointestinal

Colorectal Neoplasms

NCT05025631 2023-04-28

DOFEMCRC

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms